Table 6.
Impact of advanced fibrosis on the distribution of TG in VLDL sub-fractions analyzed using multiple regression models.
| Large VLDL-TG | Medium VLDL-TG | Small VLDL-TG | |||||||
|---|---|---|---|---|---|---|---|---|---|
| B | SE | p Value | B | SE | p Value | B | SE | p Value | |
| Constant | 7.3 | 27.9 | 0.8 | 0.0 | 14.2 | 1.0 | 3.5 | 8.0 | 0.7 |
| Advanced fibrosis | −6.1 | 4.3 | 0.16 | 0.1 | 2.2 | 0.98 | 3.2 | 1.2 | 0.01 |
| IFNL3 (Non-TT) | 6.0 | 4.7 | 0.2 | −1.3 | 2.4 | 0.6 | −1.7 | 1.4 | 0.2 |
| Female gender | −9.2 | 4.4 | 0.04 | −3.6 | 2.2 | 0.1 | −0.3 | 1.3 | 0.8 |
| HCV-RNA | 4.3 | 2.5 | 0.1 | 2.3 | 1.3 | 0.1 | 1.2 | 0.7 | 0.1 |
| BMI | 0.4 | 0.6 | 0.5 | 0.08 | 0.3 | 0.8 | 0.04 | 0.2 | 0.8 |
| HbA1c | −2.4 | 3.3 | 0.5 | 0.2 | 1.7 | 0.91 | −0.6 | 0.9 | 0.5 |